Jim Stoppani, Ph.D
It is safe, accessible, and it acts right where you put it, with no downtime
Current recommendations remain based on experts opinions, and the evidence is rather limited
The rebound effect reflects how deeply GLP-1 medications influence appetite regulation centers in the hypothalamus
Patients should discuss cannabis use openly with their GP or diabetes specialist to enable appropriate monitoring and individualised clinical advice
In many diabetes cardiovascular outcome trials, average weight loss was relatively modest, yet the reduction in cardiovascular events was meaningful, suggesting additional biology at play beyond lighter body, healthier heart. 2) The timeline doesnt always match weight loss explains it all. Weight loss is a gradual process, but cardiovascular risk reduction can begin earlier than youd expect if weight loss were the only driver